The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ESMO 2026 | Airborne carcinogen exposure and lung cancer risk in urban Rhode Island

Hina Khan, MD, Brown University, Providence, RI, discusses neighborhood-level fine particulate matter (PM2.5) exposure across Providence, Rhode Island, measured by the Breathe Providence Project, and its potential link to the state’s elevated lung cancer incidence. Although annual averages were near World Health Organization guidelines at some sites, daily limits were exceeded far more often than recommended, particularly during summer months, possibly reflecting wildfire activity. This interview took place at the European Society for Medical Oncology (ESMO) 2026 Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

So PM2.5, or particulate matter 2.5, is fine particulate matter less than 2.5 micrometers in diameter, and it’s considered a Group 1 carcinogen as classified by the International Agency for Research on Cancer. The WHO has recommended safe levels across the world of less than 5 micrograms per cubic meter for an annual average and less than 15 micrograms per cubic meter for a 24-hour average, and these higher levels should not be exceeded more than three to four days per year...

So PM2.5, or particulate matter 2.5, is fine particulate matter less than 2.5 micrometers in diameter, and it’s considered a Group 1 carcinogen as classified by the International Agency for Research on Cancer. The WHO has recommended safe levels across the world of less than 5 micrograms per cubic meter for an annual average and less than 15 micrograms per cubic meter for a 24-hour average, and these higher levels should not be exceeded more than three to four days per year. So, you know, for context, Rhode Island has one of the highest lung cancer incidences in the country, with 59 cases per 100,000, as opposed to a national average of 53. So we sought out, in addition to the known carcinogens, additional environmental carcinogens that could be increasing the risk of lung cancer in our state. And so we utilized ambient neighborhood-level PM2.5 monitoring through 23 monitors across the state. We collected data from certain monitors in the port area, which gets a lot of diesel and port-related industrial smoke, and then we got inland measurements. Some of the monitors were on the Brown University campus, which is more of the downtown area. So, very interestingly, what we saw is that we collected data over 2023 and 2024, and we saw that the average PM2.5 levels were significantly higher in the summers of 2023 and 2024. But the cumulative levels were higher in 2024 than they were in 2023. And so, while the summer increase in PM2.5 levels was not unanticipated because of the Canadian wildfires in the past few years and the smoke that they have brought with the winds, what we noticed is that the cumulative level was much higher in 2024. And interestingly, the number of daily exceedances in 2024 was much higher than in 2023. And these higher levels were not just seen along the port, where you would think that the wind and environmental factors would come into play. These were found also in the very inland areas of the state. So certainly, this is an area worth looking further into. We are planning to do more case-control studies in patients who have been exposed in the state, with or without lung cancer, to identify and establish a clear correlation.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.